New application of p-hydroxycinnamic acid
By applying p-hydroxycinnamic acid to the preventive treatment of noise-induced hearing loss, the problems of insufficient safety and poor compliance of existing drugs are solved, cochlear hair cells are protected, the risk of hearing loss is reduced, and a brand-new preventive treatment approach is provided.
Patent Information
- Application Number
- CN202610495531.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-04-15
- Publication Date
- 2026-05-26
AI Technical Summary
Existing drugs for treating noise-induced hearing loss have significant side effects and insufficient safety. Furthermore, there is a lack of specific drugs that can repair inner ear damage and reverse hearing loss. Current intervention methods cannot fully cover non-occupational exposure scenarios, have poor compliance, and cannot achieve preventive protection.
Using p-hydroxycinnamic acid as a natural small molecule compound, a drug for preventing and treating noise-induced hearing loss is prepared by reducing cellular oxidative stress. The appropriate dose is 25-100 mg/kg, which is used to preventively protect cochlear hair cells. It is administered orally and can cross the blood-labyrinth barrier to reach the inner ear target organ.
It significantly reduces noise damage to cochlear hair cells, improves patient compliance, reduces the risk of hearing loss, has few side effects, a wide range of applications, is suitable for long-term use, and has higher practical application value.